110 related articles for article (PubMed ID: 29518423)
41. Analysis of the inducible nitric oxide synthase gene polymorphisms in Czech patients with atopic diseases.
Holla LI; Stejskalova A; Znojil V; Vasku A
Clin Exp Allergy; 2006 Dec; 36(12):1592-601. PubMed ID: 17177683
[TBL] [Abstract][Full Text] [Related]
42. Association of polymorphisms in the mast cell chymase gene promoter region (-1903 g/A) and (TG)n(GA)m repeat downstream of the gene with bronchial asthma in children.
Hossny EM; Amr NH; Elsayed SB; Nasr RA; Ibraheim EM
J Investig Allergol Clin Immunol; 2008; 18(5):376-81. PubMed ID: 18973102
[TBL] [Abstract][Full Text] [Related]
43. CCTTT-repeat polymorphism of the inducible nitric oxide synthase is not associated with HIV pathogenesis.
Hersberger M; Bonhoeffer S; Rampini SK; Opravil M; Marti-Jaun J; Telenti A; Hänseler E; Ledergerber B; Speck RF;
Clin Exp Immunol; 2004 Sep; 137(3):566-9. PubMed ID: 15320907
[TBL] [Abstract][Full Text] [Related]
44. Role of polymorphisms of inducible nitric oxide synthase and endothelial nitric oxide synthase in idiopathic environmental intolerances.
De Luca C; Gugliandolo A; Calabrò C; Currò M; Ientile R; Raskovic D; Korkina L; Caccamo D
Mediators Inflamm; 2015; 2015():245308. PubMed ID: 25878398
[TBL] [Abstract][Full Text] [Related]
45. 85-kDa cytosolic phospholipase A2 group IValpha gene promoter polymorphisms in patients with severe asthma: a gene expression and case-control study.
Sokolowska M; Borowiec M; Ptasinska A; Cieslak M; Shelhamer JH; Kowalski ML; Pawliczak R
Clin Exp Immunol; 2007 Oct; 150(1):124-31. PubMed ID: 17672871
[TBL] [Abstract][Full Text] [Related]
46. No evidence for linkage in the promoter region of the inducible nitric oxide synthase gene (NOS2) in a Danish type 1 diabetes population.
Johannesen J; Pociot F; Kristiansen OP; Karlsen AE; Nerup J;
Genes Immun; 2000 Aug; 1(6):362-6. PubMed ID: 11196682
[TBL] [Abstract][Full Text] [Related]
47. Inducible nitric oxide synthase haplotype associated with hypertension and responsiveness to antihypertensive drug therapy.
Oliveira-Paula GH; Lacchini R; Coeli-Lacchini FB; Junior HM; Tanus-Santos JE
Gene; 2013 Feb; 515(2):391-5. PubMed ID: 23266817
[TBL] [Abstract][Full Text] [Related]
48. Outcome after BCG treatment for urinary bladder cancer may be influenced by polymorphisms in the NOS2 and NOS3 genes.
Ryk C; Koskela LR; Thiel T; Wiklund NP; Steineck G; Schumacher MC; de Verdier PJ
Redox Biol; 2015 Dec; 6():272-277. PubMed ID: 26298202
[TBL] [Abstract][Full Text] [Related]
49. Inducible and endothelial nitric oxide synthase genes polymorphism in inflammatory bowel disease.
Oliver J; Gómez-Garcia M; Vilchez JR; López-Nevot MA; Piñero A; Correro F; Nieto A; Martín J
Tissue Antigens; 2006 Apr; 67(4):326-30. PubMed ID: 16634870
[TBL] [Abstract][Full Text] [Related]
50. A functional polymorphism (-603A --> G) in the tissue factor gene promoter is associated with adult-onset asthma.
Isada A; Konno S; Hizawa N; Tamari M; Hirota T; Harada M; Maeda Y; Hattori T; Takahashi A; Nishimura M
J Hum Genet; 2010 Mar; 55(3):167-74. PubMed ID: 20150920
[TBL] [Abstract][Full Text] [Related]
51. Association of NOS2 and NOS3 gene polymorphisms with susceptibility to type 2 diabetes mellitus and diabetic nephropathy in the Chinese Han population.
Chen F; Li YM; Yang LQ; Zhong CG; Zhuang ZX
IUBMB Life; 2016 Jul; 68(7):516-25. PubMed ID: 27192959
[TBL] [Abstract][Full Text] [Related]
52. TGFB1 Gene Promoter Polymorphisms in Serbian Asthmatics.
Dragicevic S; Petrovic-Stanojevic N; Nikolic A
Adv Clin Exp Med; 2016; 25(2):273-8. PubMed ID: 27627560
[TBL] [Abstract][Full Text] [Related]
53. Question. Do NOS2 promoter polymorphisms protect against malaria?
Ascenzi P; Gradoni L; Visca P
IUBMB Life; 2004 Apr; 56(4):229-30. PubMed ID: 15230351
[No Abstract] [Full Text] [Related]
54. Two polypyrimidine tracts in the nitric oxide synthase 2 gene: similar regulatory sequences with different properties.
Motallebipour M; Rada-Iglesias A; Westin G; Wadelius C
Mol Biol Rep; 2010 Apr; 37(4):2021-30. PubMed ID: 19669598
[TBL] [Abstract][Full Text] [Related]
55. Association between the functional polymorphism C-159T in the CD14 promoter gene and nasal polyposis: potential role in asthma.
Yazdani N; Amoli MM; Naraghi M; Mersaghian A; Firouzi F; Sayyahpour F; Mokhtari Z
J Investig Allergol Clin Immunol; 2012; 22(6):406-11. PubMed ID: 23101184
[TBL] [Abstract][Full Text] [Related]
56. Nitric Oxide Synthase 2 Promoter Polymorphism Is a Risk Factor for Allergic Asthma in Children.
Nowakowska J; Sobkowiak P; Bręborowicz A; Mrówczyńska M; Wojsyk-Banaszak I; Szczepankiewicz A
Medicina (Kaunas); 2021 Dec; 57(12):. PubMed ID: 34946286
[No Abstract] [Full Text] [Related]
57. No association between the microsatellite polymorphism (TTTTA)n in the promoter of the CYP11A gene and ovarian hyperstimulation syndrome.
Ferk P; Gersak K; Teran N
J Assist Reprod Genet; 2006 Jan; 23(1):29-32. PubMed ID: 16391898
[TBL] [Abstract][Full Text] [Related]
58. Polymorphisms In The Nitric-Oxide Synthase 2 Gene And Prostate Cancer Pathogenesis.
Ryk C; de Verdier P; Montgomery E; Peter Wiklund N; Wiklund F; Grönberg H
Redox Biol; 2015 Aug; 5():419. PubMed ID: 28162285
[TBL] [Abstract][Full Text] [Related]
59. The effects of NOS1 gene on asthma and total IgE levels in Taiwanese children, and the interactions with environmental factors.
Wang TN; Tseng HI; Kao CC; Chu YT; Chen WY; Wu PF; Lee CH; Ko YC
Pediatr Allergy Immunol; 2010 Nov; 21(7):1064-71. PubMed ID: 20609134
[TBL] [Abstract][Full Text] [Related]
60. The effect of CD14 C159T polymorphism on in vitro IgE synthesis and cytokine production by PBMC from children with asthma.
Sackesen C; Birben E; Soyer OU; Sahiner UM; Yavuz TS; Civelek E; Karabulut E; Akdis M; Akdis CA; Kalayci O
Allergy; 2011 Jan; 66(1):48-57. PubMed ID: 20608916
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
